Fit For Use Assessment of Biozen as a Biometric Sensor Concentrator For Remote Patient Monitoring

reportActive / Technical Report | Accesssion Number: AD1212941 | Open PDF

Abstract:

In recent years, COVID-19 highlighted the importance of virtual health solutions with regard to improving patient health and conserving valuable hospital resources. Currently, the Defense Health Agency (DHA) does not own a remote patient-monitoring solution and relies on external commercial entities to provide the application and services. This could potentially lead to the DHA not retaining complete data ownership when patient data would reside on or traverse through commercial remote patient-monitoring solutions. This thesis evaluates BioZen, a DHA-owned biomedical sensor concentrator designed to run on a mobile phone, as a remote patient-monitoring tool. From this analysis, several key measures of effectiveness and measures of performance for remote patient-monitoring tools are identified and operationalized to measure the overall value BioZen brings to the DHA. Based on this research, it was found that the current build of BioZen, 2.0.0,is unable to meet any of the measures outlined in the study as a remote patient-monitoring tool. A future build of BioZen, or any remote patient-monitoring tool, could then be assessed using the measures of effectiveness and measures of performance within this study to determine the overall value brought to the DHA.

Security Markings

DOCUMENT & CONTEXTUAL SUMMARY

Distribution Code:
A - Approved For Public Release
Distribution Statement: Public Release.
Copyright: Not Copyrighted

RECORD

Collection: TRECMS
Subject Terms